cancer clinical trials for Gyn/Onc (OB/GYNONC)

9 Gyn/Onc (OB/GYNONC) clinical trials found. View a list of all cancer clinical trial types.

• A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

  Current Status: Open

  View links and contact information related to this clinical trial

• Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers

  Current Status: Open

  View links and contact information related to this clinical trial

• NRG-GY026: A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-Oysk (Herceptin Hylecta) or Pertuzumab, Trastuzumab, and Hyaluronidase-ZZXF (Phesgo) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma

  Current Status: Open

  View links and contact information related to this clinical trial

• A Non-Randomized Prospective Clinical Trial Comparint the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers (SOROCk)

  Current Status: Open

  View links and contact information related to this clinical trial

• A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

  Current Status: Open

  View links and contact information related to this clinical trial

• A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer

  Current Status: Open

  View links and contact information related to this clinical trial

• Targeted Agent and Profiling Utilization Registry (TAPUR) Study

  Current Status: Open

  View links and contact information related to this clinical trial

• A PHASE 1, FIRST IN HUMAN STUDY OF TORL-4-500 IN PATIENTS WITH ADVANCED CANCER

  Current Status: Not Open

  View links and contact information related to this clinical trial

• A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors

  Current Status: Not Open

  View links and contact information related to this clinical trial